Learn how PET study shows safe, targeted brain delivery of intranasal insulin, a critical step for future Alzheimer’s ...

The article by LaCasce et al entitled “Positron Emission Tomography–Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance)” (J Clin Oncol 10.1200/JCO.22.00947) was ...

The AHL2011 study (ClinicalTrials.gov identifier: NCT01358747) demonstrated that a positron emission tomography (PET)-driven de-escalation strategy after two cycles of bleomycin, etoposide, ...

The global Positron Emission Tomography (PET) market is set to witness a growth rate of 5% in the next 5 years. Growing prevalence of chronic diseases; technological advancements in ...

Positron Emission Tomography (PET) Scanners Global Market Overview 2021-2023 & 2024-2030 - ResearchAndMarkets.com February 17, 2025 10:25 AM Eastern Standard Time ...

Jubilant Radiopharma Announces Investment of $50 million (USD) to Expand Positron Emission Tomography (PET) Manufacturing Network June 24, 2024 02:15 PM Eastern Daylight Time ...

More than 500 nuclear medicine facilities are available in the government and private sectors, Union Minister of State for ...

SAN DIEGO, June 25, 2025--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment ...